Get started
Author

Bolin Chen

Observed names: B. Chen, 陳, 博林
ORCID: 0000-0002-4956-2675
Observed ORCIDs: 0000-0002-4956-2675, 0000-0003-1007-0486
OpenAlex ID: A5013666396
Universal crRNA Acylation Strategy for Robust Photo‐Initiated One‐Pot CRISPR–Cas12a Nucleic Acid Diagnostics
2024 · Pengfei Liu, Yating Lin, et al. · Angewandte Chemie International Edition · 99
PDF
Neutrophil extracellular traps promote growth of lung adenocarcinoma by mediating the stability of m6A‐mediated SLC2A3 mRNA‐induced ferroptosis resistance and CD8(+) T cell inhibition
2025 · Li Xu, Yi Kong, et al. · Clinical and Translational Medicine · 28
Rh‐endostatin plus camrelizumab and chemotherapy in first‐line treatment of advanced non‐small cell lung cancer: A multicenter retrospective study
2022 · Xingxiang Pu, QianZhi Wang, et al. · Cancer Medicine · 20
PDF
1300P A phase Ib/II trial of AK104 (PD-1/CTLA-4 bispecific antibody) in combination with anlotinib in advanced NSCLC
2021 · L. Wu, B. Chen, et al. · Annals of Oncology · 19
Deciphering the molecular and clinical characteristics of TREM2, HCST, and TYROBP in cancer immunity: A comprehensive pan-cancer study
2024 · Piao Zheng, Yejun Tan, et al. · Heliyon · 18
IGF2BP1 enhances the stability of SIK2 mRNA through m6A modification to promote non-small cell lung cancer progression
2023 · Yan Xu, Li Xu, et al. · Biochemical and Biophysical Research Communications · 14
Genomic correlates of programmed cell death ligand 1 (PD-L1) expression in Chinese lung adenocarcinoma patients
2022 · Kang Li, Jun Liu, et al. · Cancer Cell International · 13
PDF
Efficacy and safety of MCLA-129, an EGFR/c-MET bispecific antibody, in advanced non-small cell lung cancer (NSCLC).
2024 · Jie Wang, Jia Zhong, et al. · Journal of Clinical Oncology · 11
PDF
Universal crRNA Acylation Strategy for Robust Photo‐Initiated One‐Pot CRISPR–Cas12a Nucleic Acid Diagnostics
2024 · Pengfei Liu, Yating Lin, et al. · Angewandte Chemie · 11
PDF
M2 macrophage exosomal LINC01001 promotes non-small cell lung cancer development by affecting METTL3 and glycolysis pathway
2023 · Li Xu, Kang Li, et al. · Cancer Gene Therapy · 9
Illuminating cisplatin-induced ferroptosis in non-small-cell lung cancer with biothiol-activatable fluorescent/photoacoustic bimodal probes
2024 · Li Xu, Hongwen Liu, et al. · Journal of Materials Chemistry B · 6
The crosstalk between lung adenocarcinoma cells and M2 macrophages promotes cancer cell development via the SFRS1/miR-708-5p/PD-L1 axis
2025 · Li Xu, Kang Li, et al. · Life Sciences · 5
Inhibition of inflammation and infiltration of M2 macrophages in NSCLC through the ATF3 / CSF1 axis: Role of miR ‐27a‐3p
2023 · Bin Zhou, Yan Xu, et al. · International Journal of Experimental Pathology · 5
Role of radiotherapy in extensive-stage small cell lung cancer after durvalumab-based immunochemotherapy: A retrospective study
2024 · Lingjuan Chen, Yi Kong, et al. · Chinese Medical Journal · 4
P40.14 Efficacy and Safety of Endostar Combined With Camrelizumab and Chemotherapy in Treatment of Advanced NSCLC: A Multi-Center Retrospective Study
2021 · L. Wu, X. Pu, et al. · Journal of Thoracic Oncology · 3
Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study
2025 · Jingyi Wang, Bolin Chen, et al. · Therapeutic Advances in Medical Oncology · 2
Efficacy and safety of sintilimab in combination with chemotherapy for recurrent extensive-stage small cell lung cancer: a real-world retrospective study
2024 · Jingyi Wang, Shuzhi Liang, et al. · Journal of Thoracic Disease · 2
Long‐term survival of a patient with epidermal growth factor receptor ( EGFR) ‐mutant non‐small cell lung cancer ( NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report
2024 · Kang Li, Bolin Chen, et al. · Thoracic Cancer · 2
P16.04 A Phase II Clinical Study Evaluating Camrelizumab Combined With Apatinib and Albumin Paclitaxel for Advanced Non-Small CellLung Cancer
2021 · L. Wu, X. Pu, et al. · Journal of Thoracic Oncology · 2
Engineering of a low intrinsic fluorescence and chemical-stable fluorescent probe enables highly sensitive detection of biothiols and high-fidelity imaging of dihydroartemisinin-induced ferroptosis
2024 · Qiaozhen Ye, Tenglong Zou, et al. · Sensors and Actuators B Chemical · 1
Real-world evidence of immunotherapy in older adults with advanced non-small cell lung cancer: a retrospective cohort study
2026 · Yuling Zhong, Jingyi Wang, et al. · Cancer Immunology Immunotherapy
Immunotherapy rechallenge in extensive-stage small-cell lung cancer: A real-world retrospective study.
2026 · Jingyi Wang, Lin Wu, et al. · Journal of Clinical Oncology
PDF
Real-world outcomes of immunotherapy in older adults with advanced NSCLC: A retrospective cohort analysis.
2026 · Lin Wu, Yuling Zhong, et al. · Journal of Clinical Oncology
Sugemalimab for Post-PD-1 Progression in Non-small Cell Lung Cancer
2026 · Li Xu, Xingxiang Pu, et al. · Journal of Immunotherapy
Immunotherapy rechallenge in Extensive-Stage small cell lung Cancer: A Real-World retrospective study
2026 · Jingyi Wang, Yuling Zhong, et al. · Lung Cancer
Works count: 33
Citation count: 273
H-index: 9
I10-index: 9
Year
Topic
Type